InfuSystem Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 07, 2023 at 06:31 am EST
Share
InfuSystem Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 31.91 million compared to USD 27.28 million a year ago. Net income was USD 0.689 million compared to USD 0.443 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago. Diluted earnings per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.
For the nine months, sales was USD 94.01 million compared to USD 81.08 million a year ago. Net income was USD 0.8 million compared to net loss of USD 0.089 million a year ago. Basic earnings per share from continuing operations was USD 0.04. Diluted earnings per share from continuing operations was USD 0.04.
InfuSystem Holdings, Inc. is a health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The Companyâs segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Companyâs core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
INFUSYSTEM HOLDINGS, INC. 
